Burcin Halaci

Dr. Burcin Halaci


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
BHBurcin Halaci
Burcin Halaci
AKAkın KAYA
Akın KAYA
ATArzu Topeli
Arzu Topeli
Coronavirus disease 2019 (COVID-19) stands out as the major pandemic that we have experienced in the last century. As it affects every social structure, it brought the importance of intensive care support once again to the agenda of healthcare system after causing severe acute respiratory syndrome. The precautions to be taken against this virus, where our knowledge is extremely small, intensive care units take an indispensable place in pandemic planning. In this review, we aimed to emphasize the crucial points regarding intensive care management of COVID-19 patients, which we have written not only for intensivists but also for all healthcare professionals.

1 August 2021 in Respiratory Medicine
Verified
Journal Article
Closed access
BEBerrin Er
Berrin Er
MSMeltem Simsek
Meltem Simsek
MYMehmet Yildirim
Mehmet Yildirim
BHBurcin Halaci
Burcin Halaci
SOSerpil Ocal
Serpil Ocal
ATArzu Topeli
Arzu Topeli

1 October 2016 in Journal of Critical Care
Verified
Journal Article
Closed access
BHBurcin Halaci
Burcin Halaci
NUNese Unver
Nese Unver
SHSevil Oskay Halaçlı
Sevil Oskay Halaçlı
HCHande Canpinar
Hande Canpinar
EEEbru Ortac Ersoy
Ebru Ortac Ersoy
ATArzu Topeli
Arzu Topeli

22 September 2021 in Balkan Medical Journal
Verified
Journal Article
Open access
KGKursat Gundogan
Kursat Gundogan
İAİsmail Hakkı Akbudak
İsmail Hakkı Akbudak
PHPervin Hancı
Pervin Hancı
BHBurcin Halaci
Burcin Halaci
STSahin Temel
Sahin Temel
ATArzu Topeli
Arzu Topeli
There are limited data on the long-term outcomes of COVID-19 from different parts of the world. To determine risk factors of 90-day mortality in critically ill patients in Turkish intensive care units (ICUs), with respiratory failure. Retrospective, observational cohort. Patients with laboratory-confirmed COVID-19 and who had been followed up in the ICUs with respiratory failure for more than 24 hours were included in the study. Their demographics, clinical characteristics, laboratory variables, treatment protocols, and survival data were recorded. A total of 421 patients were included. The median age was 67 (IQR: 57-76) years, and 251 patients (59.6%) were men. The 90-day mortality rate was 55.1%. The factors independently associated with 90-day mortality were invasive mechanical ventilation (IMV) (HR 4.09 [95% CI: [2.20-7.63], P < .001), lactate level >2 mmol/L (2.78 [1.93-4.01], P < .001), age ≥60 years (2.45 [1.48-4.06)], P < .001), cardiac arrhythmia during ICU stay (2.01 [1.27-3.20], P = .003), vasopressor treatment (1.94 [1.32-2.84], P = .001), positive fluid balance of ≥600 mL/day (1.68 [1.21-2.34], P = .002), PaO2/FiO2 ratio of ≤150 mmHg (1.66 [1.18-2.32], P = .003), and ECOG score ≥1 (1.42 [1.00-2.02], P = .050). Long-term mortality was high in critically ill patients with COVID-19 hospitalized in intensive care units in Turkey. Invasive mechanical ventilation, lactate level, age, cardiac arrhythmia, vasopressor therapy, positive fluid balance, severe hypoxemia and ECOG score were the independent risk factors for 90-day mortality.

7 March 2023 in Chronic Illness
Verified
Journal Article
Closed access
BHBurcin Halaci
Burcin Halaci
MYMehmet Yildirim
Mehmet Yildirim
EKEsat Kivanc Kaya
Esat Kivanc Kaya
EUEge Ulusoydan
Ege Ulusoydan
EEEbru Ortac Ersoy
Ebru Ortac Ersoy
ATArzu Topeli
Arzu Topeli
Objectives: To evaluate the presence of chronic critical illness (CCI) in COVID-19 patients and compare clinical characteristics and prognosis of patients with and without CCI admitted to intensive care unit (ICU). Methods: It was a retrospective, observational study at a university hospital ICU. Patients were accepted as CCI if they had prolonged ICU stay (≥14 days) and got ≥1 score for cardiovascular sequential organ failure assessment (SOFA) score and ≥2 score in other parameters on day 14 of ICU admission which was described as persistent organ dysfunction. Results: 131 of 397 (33%) patients met CCI criteria. CCI patients were older ( p = 0.003) and frailer ( p < 0.001). Their Acute Physiology and Chronic Health Evaluation (APACHE) II and SOFA scores were higher, PaO2/FiO2 ratio was lower ( p < 0.001). Requirement of invasive mechanical ventilation (IMV), steroid use, and septic shock on admission were higher in the CCI group ( p < 0.001). CCI patients had higher ICU and hospital mortality than other patients (54.2% vs. 19.9% and 55.7% vs. 22.6%, p < 0.001, respectively). Regression analysis revealed that IMV (OR: 8.40, [5.10–13.83], p < 0.001) and PaO2/FiO2 < 150 on admission (OR: 2.25, [1.36–3.71], p = 0.002) were independent predictors for CCI. Discussion: One-third of the COVID-19 patients admitted to the ICU were considered as CCI with significantly higher ICU and hospital mortality.

10 October 2022 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
MYMehmet Yildirim
Mehmet Yildirim
BHBurcin Halaci
Burcin Halaci
DYDeniz Yuce
Deniz Yuce
YGYunus Gunegul
Yunus Gunegul
EEEbru Ortac Ersoy
Ebru Ortac Ersoy
ATArzu Topeli
Arzu Topeli
Purpose: We aimed to evaluate the relation between admission COVID-19 associated hyperinflammatory syndrome (cHIS) score and intensive care unit (ICU) outcomes. Materials and Methods: Patients with laboratory confirmed COVID-19 admitted to our ICU between 20th March 2020-15th June 2021 were included. Patients who received immunomodulatory treatment except corticosteroids were excluded. Main outcomes were ICU mortality and invasive mechanical ventilation (IMV) requirement after ICU admission. Results: Three hundred and seventy patients with a median (IQR) age of 66 (56-77) were analyzed. Median admission cHIS score was 3 (2-4). A cHIS score ≥3 was found to be associated with ICU mortality (sensitivity = 0.63, specificity = 0.50; p < 0.01) and IMV requirement after ICU admission (sensitivity = 0.61, specificity = 0.51; p < 0.01). Patients with an admission cHIS score ≥3 (n = 199) had worse median admission APACHEII, SOFA scores and PaO2/FiO2 ratio than others (n = 171) (p < 0.01). IMV requirement after ICU admission (38.5% vs 26.1%;p = 0.03), ICU (36.2% vs 25.1%;p = 0.02), hospital (39.1% vs 26.9%;p = 0.01) and 28th day (28.1% vs 19.1%;p = 0.04) mortality were higher in patients with admission cHIS score ≥3 than others (p < 0.01). Age <65 years, malignancy and higher admission SOFA score were independent variables associated with admission cHIS score ≥3. Conclusion: Critically-ill COVID-19 patients with admission cHIS score ≥3 have worse disease severity and outcomes than other patients.